Skip to content
ChickenStockChickenStock
ResearchINSM
Insmed logo

Insmed (INSM) stock

NASDAQ

$121.16+2.62%(+3.09)

As of the Nov 13, 2026 close (U.S. Eastern)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

-43.86x

Net loss — not comparable

P/B

36.55x

P/S

17.47x

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue increased 269.0% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Oct 29, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

16 SEC filings
  • Koppikar UtpalDirector · Oct 19, 2026Grant or award6,139 shares
    6,139 shares held after
  • Hudson PaulDirector · Oct 19, 2026Grant or award6,139 shares
    6,139 shares held after
  • Brennan David RDirector · Sep 9, 2026Open-market sale25,000 shares · $3.1M
    Avg. price $12439,238 shares held after
  • SHAROKY MELVIN MDDirector · Aug 17, 2026Open-market sale5,000 shares · $638K
    Avg. price $127.530 shares held after
  • Adsett RogerChief Operating Officer · Aug 10, 2026Open-market sale239,850 shares · $32.0M
    Avg. price $133.2798,744 shares held after
  • Adsett RogerChief Operating Officer · Aug 10, 2026Option exercise239,850 shares · $4.9M
    Avg. price $20.4527
    Show 3 price lots
    • 80,970 shares × $30.46$2.5M
    • 76,600 shares × $17.16$1.3M
    • 82,280 shares × $13.67$1.1M
  • Flammer Martina M.D.Chief Medical Officer · Aug 6, 2026Open-market sale27,173 shares · $3.5M
    Avg. price $128.6144
    Show 2 price lots
    • 18,278 shares × $129.4$2.4M
    • 8,895 shares × $127$1.1M
  • Flammer Martina M.D.Chief Medical Officer · Aug 6, 2026Option exercise27,173 shares · $576K
    Avg. price $21.2021
    Show 2 price lots
    • 18,278 shares × $18.95$346K
    • 8,895 shares × $25.83$230K
  • Lewis WilliamChair and CEO · Jul 23, 2026Open-market sale10,700 shares · $1.1M
    Avg. price $106.0645
    Show 2 price lots
    • 5,872 shares × $106.43$625K
    • 4,828 shares × $105.62$510K
  • Lewis WilliamChair and CEO · Jul 23, 2026Option exercise10,700 shares · $267K
    Avg. price $24.9411
    Show 2 price lots
    • 6,260 shares × $30.46$191K
    • 4,440 shares × $17.16$76K

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Insmed (INSM) stock information

NASDAQ

Insmed (INSM) is listed on NASDAQ. Its market capitalization is about $26.5B. On trailing-twelve-month earnings the P/E ratio is -43.86, and the P/B ratio is 36.55. Return on equity is -83.3%. These figures are computed in-house from official filings and are reference information only.

Insmed — frequently asked questions

What is the P/E ratio of Insmed (INSM)?
On a trailing-twelve-month basis, INSM trades at a P/E ratio of -43.86. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Insmed?
INSM has a market capitalization of about $26.5B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.